Who to call at OS Therapies Incorporated, and when
Fundz watches for the moments OS Therapies Incorporated starts buying, and tells you who to reach.
- An alert the day OS Therapies Incorporated raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OS Therapies Incorporated, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OS Therapies Incorporated. With Fundz connected, it knows.
OS Therapies Incorporated
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
ostherapies.comAI Executive Summary
AI-powered analysis of 8-K filing content
At its October 21, 2025 annual meeting, OS Therapies stockholders approved an amendment to the 2023 Incentive Compensation Plan that raises the plan's share reserve from 4 million to 10 million shares. Stockholders also approved raising authorized common stock from 50 million to 150 million shares and a share issuance to Ayala Pharmaceuticals of 20% or more of outstanding common stock, which together signal significant potential dilution.
Key Takeaways
Stockholders approved the Plan Amendment, increasing the share reserve under the 2023 Incentive Compensation Plan from 4 million to 10 million shares, and raising the per-person grant limit.
Stockholders approved increasing authorized common stock from 50 million to 150 million shares through a charter amendment.
2 more takeaways
Related Filings (3)
3 more filings from OS Therapies Incorporated in the last 90 days
Filing Overview
What This Means
OS Therapies Incorporated filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.